Actively Recruiting
Use of Biologics for Severe Asthma in Hong Kong
Led by Chinese University of Hong Kong · Updated on 2026-03-19
360
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The landscape of biologics therapy used in Hong Kong is currently unknown. The purpose of this study is to conduct a retrospective analysis of the use of biologics treatment for severe asthma in Hong Kong. The study aims to assess the landscape of biologics usage, evaluate the characteristics and conditions of patients before and after receiving biologic therapy, and provide insights into the effectiveness and safety of these treatments in the local population.
CONDITIONS
Official Title
Use of Biologics for Severe Asthma in Hong Kong
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Diagnosed with severe asthma according to Global Initiative for Asthma (GINA) guidelines
- Have received biologic therapy for asthma treatment, including those with only one dose
You will not qualify if you...
- Having other significant respiratory diseases such as tuberculosis-destroyed lung parenchyma
- History of lung resection
- Lung cancer diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, NT, HK
Hong Kong, Hong Kong
Actively Recruiting
Research Team
F
Fanny WS Ko, MD
CONTACT
D
David SC Hui, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here